Atorvastatin Export Market Intelligence: India's 477 Suppliers Shipping to 145 Countries — TransData Nexus 2026

Q: Who are the top atorvastatin exporters from India?

The top atorvastatin exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $265.9M (24.6% market share); 2. PIRAMAL PHARMA LIMITED — $241.6M (22.4% market share); 3. MYLAN LABORATORIES LIMITED — $158.2M (14.6% market share); 4. MSN LABORATORIES PRIVATE LIMITED — $83.7M (7.7% market share); 5. ALKEM LABORATORIES LIMITED — $41.5M (3.8% market share). Together they account for 73.2% of India's total atorvastatin export value.

Q: What is the total export value of atorvastatin from India?

The total export value of atorvastatin from India is $1.1B USD, recorded across 15,000 shipment transactions from 477 active exporters to 145 destination countries. The average shipment value is $72.0K.

Q: Which countries import atorvastatin from India?

India exports atorvastatin to 145 countries worldwide. The top importing countries are: UNITED STATES (52.5% share, $567.7M), CANADA (25.9% share, $279.4M), MALTA (3.0% share, $32.5M), UNITED KINGDOM (2.8% share, $30.2M), JAPAN (2.5% share, $26.8M). These five markets account for 86.7% of total export value.

Q: What is the HS code for atorvastatin exports from India?

The primary HS code for atorvastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of atorvastatin exports from India?

The average unit price for atorvastatin exports from India is $6.13 USD per unit, with prices ranging from $0.00 to $5113.40 depending on formulation, packaging, and order volume. The total market is valued at $1.1B across 15,000 shipments.

Q: Which ports handle atorvastatin exports from India?

The primary ports for atorvastatin exports from India are HYDERABAD ICD (13.6% of shipments), HYDERABAD ICD (INSNF6) (7.5% of shipments), NHAVA SHEVA SEA (INNSA1) (5.6% of shipments), SAHAR AIR (5.6% of shipments), JNPT/ NHAVA SHEVA SEA (5.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of atorvastatin?

India is one of the world's leading exporters of atorvastatin due to its large base of 477 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports atorvastatin to 145 countries, demonstrating 74% global market coverage.

Q: What certifications do Indian atorvastatin exporters need?

Indian atorvastatin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import atorvastatin from India?

There are 1,291 registered buyers importing atorvastatin from India, spread across 145 countries. The repeat buyer rate is 69.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top atorvastatin supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading atorvastatin exporter from India with a market share of 24.6% and total export value of $265.9M across 328 shipments. The top 5 suppliers together control 73.2% of total export value.

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Atorvastatin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Atorvastatin to the World

Between 2022 and 2026, India exported $1.1B worth of atorvastatin across 15,000 verified shipments to 145 countries — covering 74% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (52.5%). INTAS PHARMACEUTICALS LIMITED leads with a 24.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Atorvastatin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Atorvastatin export data snapshot — $1.1B · 477 exporters · 145 countriesTransData Nexus · Indian Customs Data

Top Atorvastatin Exporters from India

477 active exporters · Ranked by export value

View all 477 →

Top Atorvastatin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$265.9M	328	10	24.6%
2	PIRAMAL PHARMA LIMITED

Top Countries Importing Atorvastatin from India

145 destination markets · Ranked by import value

All 145 countries →

Top Countries Importing Atorvastatin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$567.7M	52.5%
2	CANADA	$279.4M	25.9%
3	MALTA	$32.5M	3.0%
4	UNITED KINGDOM	$30.2M	2.8%
5	JAPAN	$26.8M	2.5%
6	CHILE	$17.3M	1.6%
7	BELGIUM	$17.0M	1.6%
8	AUSTRALIA	$14.6M	1.3%
9	SRI LANKA	$10.5M	1.0%
10	PHILIPPINES	$9.1M	0.8%

UNITED STATES is India's largest atorvastatin export destination, absorbing 52.5% of total exports worth $567.7M. The top 5 importing countries — UNITED STATES, CANADA, MALTA, UNITED KINGDOM, JAPAN — together account for 86.7% of India's total atorvastatin export value. The remaining 140 destination countries collectively receive the other 13.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Atorvastatin to India?

31 origin countries · Total import value: $6.6M

India imports atorvastatin from 31 countries with a combined import value of $6.6M. The largest supplier is CROATIA ($3.5M, 127 shipments), followed by CANADA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Atorvastatin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CROATIA	$3.5M	127	53.0%
2	CANADA	$2.5M	80	37.7%
3	UNITED KINGDOM	$376.0K	19	5.7%
4	UNITED STATES	$112.9K	25	1.7%
5	GERMANY	$40.8K	27	0.6%
6	BRAZIL	$14.8K	15	0.2%
7	IRELAND	$12.6K	9	0.2%
8	CHINA	$10.1K	10	0.2%
9	MALTA	$9.3K	22	0.1%
10	AUSTRIA	$7.6K	2	0.1%

Showing top 10 of 31 origin countries

CROATIA is the largest supplier of atorvastatin to India, accounting for 53.0% of total import value. The top 5 origin countries — CROATIA, CANADA, UNITED KINGDOM, UNITED STATES, GERMANY — together supply 98.7% of India's atorvastatin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Atorvastatin — Export Intelligence Video

Visual overview of India's atorvastatin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's atorvastatin pharmaceutical import and export market — $1.1B in total trade, 477 verified manufacturers, and 145 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Atorvastatin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, atorvastatin is approved through Abbreviated New Drug Applications (ANDAs), allowing generic versions to enter the market. The FDA's Orange Book lists multiple approved ANDAs for atorvastatin, indicating a competitive generic landscape. The FDA's import alert database does not currently list atorvastatin, suggesting no active import restrictions on this product. Given that 52.5% of India's atorvastatin exports are destined for the U.S., the absence of import alerts is favorable for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, atorvastatin is subject to marketing authorization by the European Medicines Agency (EMA). The EMA has conducted periodic safety update report single assessments (PSUSAs) for atorvastatin, with the most recent in October 2024, resulting in variations to the product information. These assessments ensure ongoing pharmacovigilance and compliance with EU Good Manufacturing Practice (GMP) requirements. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and monitoring of atorvastatin, aligning with similar standards.

3WHO Essential Medicines & Global Standards

Atorvastatin is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in global health. It is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different markets.

4India Regulatory Classification

In India, atorvastatin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, atorvastatin is not currently listed under price control, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceuticals, but atorvastatin is generally exempt from such requirements, facilitating smoother export processes.

5Patent & Exclusivity Status

The primary patents for atorvastatin have expired, leading to a robust generic market with multiple manufacturers producing the drug. This has resulted in increased competition and more affordable pricing globally.

6Recent Industry Developments

In December 2025, the EMA completed a PSUSA for the combination of amlodipine and atorvastatin, leading to updates in product information to enhance patient safety. In January 2025, the FDA updated import alerts to reinforce that all unauthorized e-cigarettes may be detained without physical examination, reflecting the agency's commitment to regulating tobacco products. In August 2024, the EMA concluded a PSUSA for atorvastatin, resulting in variations to the product information to address new safety data. In June 2019, the EMA conducted a PSUSA for atorvastatin/ezetimibe, leading to updates in the product information to ensure continued safety and efficacy. In August 2018, the EMA completed a PSUSA for atorvastatin, resulting in harmonized prescribing information across the EU.

These developments highlight the dynamic regulatory environment surrounding atorvastatin, emphasizing the importance of continuous monitoring and compliance for stakeholders involved in its production and distribution.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Atorvastatin

Retail & reference prices across 9 markets vs. India FOB export price of $6.13/unit

Global Price Benchmark for Atorvastatin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.26	USD	According to the FDA's Orange Book, multiple generic versions of atorvastatin are approved, contributing to competitive pricing.
United Kingdom	$0.07	GBP	The NHS Drug Tariff sets the reimbursement price for atorvastatin 10mg tablets, ensuring affordability within the public healthcare system.
Germany	$0.11	EUR	The Federal Joint Committee (G-BA) oversees the pricing and reimbursement of pharmaceuticals, including atorvastatin, within the statutory health insurance system.
Australia

Supply Chain Risk Assessment — Atorvastatin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Atorvastatin, a widely prescribed statin for lowering cholesterol, is primarily manufactured in India, which has established itself as a global hub for pharmaceutical production. However, the production of Atorvastatin's Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) imported from China. This dependency poses significant risks, as any disruption in the supply of these KSMs can directly impact the availability of the final product. For instance, in October 2025, the U.S. Pharmacopeia highlighted that 58% of KSMs used for U.S.-approved APIs are sourced from a single country, underscoring the vulnerability of the supply chain.

The COVID-19 pandemic further exposed these vulnerabilities, with lockdowns and export restrictions in China leading to supply chain disruptions. Although the situation has stabilized, the underlying risk remains due to the concentrated sourcing of critical raw materials. This reliance on a single country for essential KSMs necessitates strategic measures to diversify sourcing and enhance supply chain resilience.

2Supplier Concentration & Single-Source Risk

TransData Nexus's proprietary trade data indicates that the top five Indian exporters of Atorvastatin account for 73.2% of total exports, with INTAS PHARMACEUTICALS LIMITED alone contributing 24.6%. This high supplier concentration amplifies the risk of supply disruptions, as issues affecting these key players can have a disproportionate impact on global availability.

Access Complete Atorvastatin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 145 markets.

Request Demo View Pricing

Frequently Asked Questions — Atorvastatin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top atorvastatin exporters from India?

The leading atorvastatin exporters from India are INTAS PHARMACEUTICALS LIMITED, PIRAMAL PHARMA LIMITED, MYLAN LABORATORIES LIMITED, and 12 others. INTAS PHARMACEUTICALS LIMITED leads with 24.6% market share ($265.9M). The top 5 suppliers together control 73.2% of total export value.

What is the total export value of atorvastatin from India?

The total export value of atorvastatin from India is $1.1B, recorded across 15,000 shipments from 477 active exporters to 145 countries. The average shipment value is $72.0K.

Which countries import atorvastatin from India?

India exports atorvastatin to 145 countries. The top importing countries are UNITED STATES (52.5%), CANADA (25.9%), MALTA (3.0%), UNITED KINGDOM (2.8%), JAPAN (2.5%), which together account for 86.7% of total export value.

What is the HS code for atorvastatin exports from India?

The primary HS code for atorvastatin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Atorvastatin

Atorvastatin

Top Atorvastatin Exporters from India

Top Countries Importing Atorvastatin from India

Who Supplies Atorvastatin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Atorvastatin — Export Intelligence Video

Regulatory Landscape — Atorvastatin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Atorvastatin

Supply Chain Risk Assessment — Atorvastatin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Atorvastatin Trade Intelligence

Frequently Asked Questions — Atorvastatin Exports from India

Who are the top atorvastatin exporters from India?

What is the total export value of atorvastatin from India?

Which countries import atorvastatin from India?

What is the HS code for atorvastatin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of atorvastatin exports from India?

Which ports handle atorvastatin exports from India?

Why is India a leading exporter of atorvastatin?

What certifications do Indian atorvastatin exporters need?

How many buyers import atorvastatin from India?

What is the market share of the top atorvastatin exporter from India?

Analysis Methodology